جاري التحميل...
جاري تحميل محتوى الصفحةجاري التحميل...
جاري تحميل محتوى الصفحةlanzofutal 15 mg 10 caps
description lansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. it is manufactured by tap pharmaceutical products mechanism of action lansoprazole belongs to a class of antisecretory compounds the substituted benzimidaz
Drug Monograph — lansoprazole
12.1 Mechanism of Action Lansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the (H + , K + )-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. Lansoprazole does not exhibit anticholinergic or histamine type-2 antagonist activity.
هذه المعلومات الدوائية مُستخلصة من مصادر طبية موثوقة (FDA/Altibbi) وهي للتثقيف الصحي العام فقط، ولا تُغني عن استشارة الصيدلي أو الطبيب المختص. لا تبدأ أو توقف أو تغيّر جرعة أي دواء بدون إشراف طبي.
00 · Empty
لا توجد تقييمات معتمدة لهذا المنتج بعد. كن أول من يقيّم!